Recent Finacing
Recent Raise
Signadori Bio is a preclinical-stage biopharmaceutical company developing an off-the-shelf, in vivo engineered monocyte immunotherapy platform to treat solid tumours.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at Signadori Bio.
